Tag: Prescription Drug User Fee Act

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Prescription Drug User Fee Act

Food and Drug Amendments of 2022 (PDUFA VII) | Alston & Bird - JDSupra

Added to Collection on: 2022-06-15 18:47:36

Tags for this article:

Food and Drug Administration
Health sciences
Health
Prescription Drug User Fee Act
Good manufacturing practice
New Drug Application
Clinical trial
Dietary supplement
FDA Center for Devices and Radiological Health
Medical device
Food and Drug Administration Modernization Act
PDUFA date

Click the tags to see associated articles and topics

View Article Details
AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel ...

Added to Collection on: 2022-10-02 21:06:44

Tags for this article:

Health
Medicine
Monoclonal antibodies
Durvalumab
Food and Drug Administration
Priority review
Prescription Drug User Fee Act
AstraZeneca
Hepatocellular carcinoma
Indication

Click the tags to see associated articles and topics

View Article Details
AstraZeneca-Merck prostate cancer combination drug, 3rd trial - Press Release

Added to Collection on: 2022-10-02 20:25:26

Tags for this article:

Articles
Health
Life Sciences
Food and Drug Administration
Pharmaceuticals policy
Prescription Drug User Fee Act
Alnylam Pharmaceuticals
Pharmaceutical industry
Gene therapy

Click the tags to see associated articles and topics

View Article Details
BioMarin Pharmaceutical Inc. (BMRN) Q3 2022 Earnings Call Transcript | AlphaStreet

Added to Collection on: 2022-10-29 03:47:30

Tags for this article:

Companies
BioMarin Pharmaceutical
Virotherapy
Iduronidase
Articles
Health
BlackBerry Limited
Forward-looking statement
Prescription Drug User Fee Act
BioMarin Pharmaceutical Inc.
Brian Mueller
J.J. Bienaime
Hank Hank Fuchs
Cantor Fitzgerald
Stifel Financial Corp.
Jeff Jeff Ajer
United States
RBC Capital Markets
Kuvan
Guggenheim Partners
Jeff Ajer

Click the tags to see associated articles and topics

View Article Details
The FDA's Present and Future, with Commissioner Robert Califf, MD - HCPLive

Added to Collection on: 2022-12-23 17:04:27

Tags for this article:

Health
Articles
Food and Drug Administration
Life Sciences
Pharmaceuticals policy
Pharmaceutical industry
Drug discovery
Pharmacy
Fast track
Prescription Drug User Fee Act
Priority review
Accelerated approval
United States

Click the tags to see associated articles and topics

View Article Details
5 Key FDA Decisions Expected in the First Quarter of 2023 - HCPLive

Added to Collection on: 2022-12-31 20:23:49

Tags for this article:

Branches of biology
Health
Medicine
RTT
Breakthrough therapy
Food and Drug Administration
Aflibercept
Bayer AG
Anti–vascular endothelial growth factor therapy
Prescription Drug User Fee Act
Macular edema
Diabetic retinopathy

Click the tags to see associated articles and topics

View Article Details
Regeneron's bispecific lymphoma antibody odronextamab wins FDA priority review

Added to Collection on: 2023-09-30 00:33:25

Tags for this article:

Antineoplastic drugs
Orphan drugs
Breakthrough therapy
Lymphoma
Cancer immunotherapy
Diffuse large B-cell lymphoma
Regeneron Pharmaceuticals
Food and Drug Administration
Prescription Drug User Fee Act
B-cell maturation antigen
Pembrolizumab
Umbralisib

Click the tags to see associated articles and topics

View Article Details
Bristol Myers Squibb Takes Over Karuna Therapeutics - CHEManager

Added to Collection on: 2023-12-23 22:22:21

Tags for this article:

Muscarinic agonists
KarXT
Xanomeline
Bristol-Myers Squibb
Prescription Drug User Fee Act
Trospium chloride
Antipsychotic

Click the tags to see associated articles and topics

View Article Details
Astellas Provides Update on Zolbetuximab Biologics License Application in U.S. | Antibodies

Added to Collection on: 2024-01-09 15:19:16

Tags for this article:

Food and Drug Administration
Astellas Pharma
Mitsubishi UFJ Financial Group
Monoclonal antibodies
Zolbetuximab
CLDN18
Prescription Drug User Fee Act
Biologics license application
u.s. food and drug administration
Astellas Pharma Inc.

Click the tags to see associated articles and topics

View Article Details
PDUFA Date Coming Up for U.K. Biopharma - The Streetwise Reports

Added to Collection on: 2024-04-23 09:03:57

Tags for this article:

Food and Drug Administration
Pharmaceuticals policy
Canaccord Genuity
Genuity
Prescription Drug User Fee Act
Securities research
Financial Industry Regulatory Authority
Financial analyst
Investment banking
PDUFA date
Pharmaceutical industry in China
Chronic obstructive pulmonary disease
United Kingdom
Verona Pharma plc
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details